Amarantus Bioscience Holdings Inc (AMBS)

[Sir Francelote]

This is definitely music to my ears.

The fact that Amarantus was able to go back to many of the original investors from the September and October 2013 private placement is a huge plus. Many of these investors are increasing their position and have agreed to a continued "no shorting" provision. This suggests to us that the funds backing Amarantus are taking a long-term fundamental position in the company.